Τετάρτη 26 Απριλίου 2017

Osimertinib receives full approval in the EU

The European Commission (EC) has granted full marketing authorisation for osimertinib 40mg and 80mg once-daily tablets for the treatment of adult patients with locally-advanced or metastatic epidermal growth factor receptor (EGFR) T790M...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2owAwQ8
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις